Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.

@article{Ritchie2005MultifactorDR,
  title={Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.},
  author={Marylyn DeRiggi Ritchie and Alison A. Motsinger},
  journal={Pharmacogenomics},
  year={2005},
  volume={6 8},
  pages={
          823-34
        }
}
In the quest for discovering disease susceptibility genes, the reality of gene-gene and gene-environment interactions creates difficult challenges for many current statistical approaches. In an attempt to overcome limitations with current disease gene detection methods, the multifactor dimensionality reduction (MDR) approach was previously developed. In brief, MDR is a method that reduces the dimensionality of multilocus information to identify polymorphisms associated with an increased risk of… 

Figures and Tables from this paper

Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.
TLDR
The multi-factor dimensionality reduction (MDR) method seems promising, because it provides a limited number of statistically stable interactions; however the biological interpretation remains to be understood.
Exploring epistasis in candidate genes for rheumatoid arthritis
TLDR
This work applied two computational methods, namely multifactor dimensionality reduction (MDR) and grammatical evolution neural networks (GENN), to three data sets from GAW15, and identified a strong single locus effect of a single-nucleotide polymorphism in PTPN22 that is significantly associated with RA.
Multifactor dimensionality reduction reveals gene–gene interactions associated with multiple sclerosis susceptibility in African Americans
TLDR
A highly efficient multilocus genotyping assay representing variation in 34 genes associated with inflammatory pathways is used to explore gene–gene interactions and disease susceptibility in a well-characterized African-American case–control MS data set, and the multifactor dimensionality reduction (MDR) test is applied to detect epistasis.
Assessing Gene-Gene Interactions in Pharmacogenomics
TLDR
Several promising methods for addressing gene-gene interactions in pharmacogenomics studies are outlined and some candidate gene studies for various treatments with consideration of gene- gene interactions are summarized.
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury
TLDR
It is suggested that machine learning approaches may help identify gene–gene interactions as potential risk factors for better assessing complicated diseases such as DILI chronicity.
Discussing gene‐gene interaction: Warning — translating equations to English may result in Jabberwocky
TLDR
Two clear trends emerged across the analyses: first, the methods for quantitative trait gene × gene interaction appeared to perform very well, even in families initially ascertained as affected sib pairs; and second, dichotomous trait gene → gene interaction methods failed to produce consistent results.
Neural networks for modeling gene-gene interactions in association studies
TLDR
A simulation study to compare neural networks with two standard methods shows that neural networks are more successful in modeling the structure of the underlying disease model than logistic regression models in most of the investigated situations.
An R package implementation of multifactor dimensionality reduction
TLDR
A package for the R statistical language to implement the Multifactor Dimensionality Reduction (MDR) method for nonparametric variable selection of interactions is introduced, designed to provide an alternative implementation for R users, with great flexibility and utility for both data analysis and research.
Power of grammatical evolution neural networks to detect gene-gene interactions in the presence of error
TLDR
This study examines the power of GENN to detect interesting interactions in the presence of noise due to genotyping error, missing data, phenocopy, and genetic heterogeneity, and compares it to that of another computational method – Multifactor Dimensionality Reduction.
...
...

References

SHOWING 1-10 OF 79 REFERENCES
Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions
TLDR
A multifactor dimensionality reduction (MDR) method for collapsing high-dimensional genetic data into a single dimension thus permitting interactions to be detected in relatively small sample sizes is developed.
Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity
TLDR
Using simulated data, multifactor dimensionality reduction has high power to identify gene‐gene interactions in the presence of 5% genotyping error, 5% missing data, phenocopy, or a combination of both, and MDR has reduced power for some models in the Presence of 50% Phenocopy and very limited power in the absence of genetic heterogeneity.
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.
One of the greatest challenges facing human geneticists is the identification and characterization of susceptibility genes for common complex multifactorial human diseases. This challenge is partly
Computational analysis of gene-gene interactions using multifactor dimensionality reduction
  • J. Moore
  • Biology
    Expert review of molecular diagnostics
  • 2004
TLDR
A novel strategy known as multifactor dimensionality reduction that was specifically designed for the identification of multilocus genetic effects is presented and several case studies that demonstrate the detection of gene–gene interactions in common diseases such as atrial fibrillation, Type II diabetes and essential hypertension are discussed.
A novel method to identify gene–gene effects in nuclear families: the MDR‐PDT
TLDR
A novel test, the multifactor dimensionality reduction‐PDT, is developed by merging the MDR method with the genotype‐Pedigree Disequilibrium Test (geno‐ PDT), which allows identification of single‐locus effects or joint effects of multiple loci in families of diverse structure.
Extension of multifactor dimensionality reduction for identifying multilocus effects in the GAW14 simulated data
TLDR
The non-cross-validation test can provide accurate results with the advantage of high efficiency compared to 10- Crossvalidation, and the non-fixed permutation test provides a good compromise between power and false-positive rate.
Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus
TLDR
A two-locus interaction between the UCP2 and PPARγ genes among 23 loci in the candidate genes of Type 2 diabetes was shown using the MDR method, which showed the maximum consistency and minimum prediction error among all gene to gene interaction models evaluated.
New strategies for identifying gene-gene interactions in hypertension
TLDR
The general problem of identifying gene-gene interactions is reviewed and several traditional and several newer methods that are being used to assess complex genetic interactions in essential hypertension are described.
Ideal discrimination of discrete clinical endpoints using multilocus genotypes
TLDR
It is concluded that MDR ideally discriminates between low risk and high risk subjects using attributes constructed from multilocus genotype data, similar to that of a naive Bayes classifier.
Multilocus Analysis of Hypertension: A Hierarchical Approach
TLDR
The data indicate epistatic interactions play a major role in hypertension susceptibility and support a model where multiple pathways need to be affected in order to predispose to hypertension.
...
...